Disclosure: This guide is published by LevelsRx, which is one of the platforms ranked below. We have a financial interest in the platform we rank first. Scores on this page are our own editorial assessments — they are not based on patient outcomes, independent testing, or clinical trials.
For informational purposes only — not medical advice. GLP-1 and other weight-management medications require a prescription from a licensed healthcare provider, and eligibility is determined case by case following a clinical evaluation. A consultation does not guarantee a prescription. Consult a qualified healthcare provider before starting any weight-loss medication.
In This Guide
- The Concise Overview
- The 9 Platforms
- Evaluation Methodology For 2026
- Aligning Clinics With Specific Objectives
- Practices To Approach With Caution
- Commonly Raised Questions
Every major online weight management provider is analyzed by clinical standards, stated out-of-pocket expenses, coverage assistance, and program structure.
The Concise Overview
Top overall for commercial coverage: LevelsRx — clinical care with a dedicated prior authorization team.
Comprehensive metabolic testing: Calibrate — detailed lab analysis with intensive lifestyle coaching.
Broadest medication accessibility: Found — access to diverse pathways beyond standard injectables.
Fastest onboarding: Sesame Care — same-day appointments and rapid consultations.
Strongest specialist network: Accomplish Health — access to clinicians practicing in obesity medicine.
The 9 Platforms
LevelsRx
Editorial score: 4.9 · Clinical pathways · Coverage advocacy
Combines medication management with insurance navigation, including a prior authorization team that files documentation and manages appeals at no additional charge, plus ongoing provider support throughout treatment. Prior authorization support cannot guarantee that your insurer will approve coverage. Monthly pricing includes medication (if prescribed), clinician support, provider visits, and shipping—there’s no separate membership fee. Injectable compounded semaglutide is $249 per month after the $139 first month; oral compounded semaglutide is $269 per month; and compounded tirzepatide is $349 per month. Prepaid 3-, 6-, and 12-month packages offer lower effective monthly rates and are paid in full upfront. Some first-month promotional offers may require a 3-month minimum commitment; confirm applicable terms at checkout.
Calibrate
Editorial score: 4.5 · Intensive metabolic reset
Focuses heavily on bi-weekly coaching and foundational lifestyle changes alongside standard pharmacological interventions. FDA-approved weight-management medications are labeled for use alongside a reduced-calorie diet and increased physical activity.
Found
Editorial score: 4.3 · Varied pharmaceutical pathways
Offers a range of oral prescription medications in addition to injectables. Some are FDA-approved for weight management and some are prescribed off-label, meaning they were not FDA-approved for that specific use. Ask your provider which category any medication you are prescribed falls into.
Sequence
Editorial score: 4.4 · Fitness integration · Care coordination
Integrates dedicated fitness and nutrition planning directly into the primary medical framework with dedicated care coordinators.
Alfie Health
Editorial score: 4.2 · Data-assisted precision care
Uses proprietary software to help analyze metabolic profiles and support clinician decision-making. A licensed provider reviews and makes the final determination on any treatment plan.
FuturHealth
Editorial score: 4.0 · Dietitian-led nutrition
Pairs pharmaceutical access with customized meal planning delivered by registered dietitians.
Accomplish Health
Editorial score: 4.7 · Specialist-driven telemedicine
States that it connects patients with clinicians practicing in obesity medicine rather than general practitioners. Individual clinician credentials can be verified through your state medical board.
Mayo Clinic Diet
Editorial score: 4.1 · Established medical programming
A digitally adapted behavioral program designed to complement prescribed treatments; it is not a prescribing telehealth service. Described here from its public materials — Mayo Clinic has no affiliation with LevelsRx and has not endorsed this guide.
Sesame Care
Editorial score: 3.9 · Direct-pay marketplace
A fast, transparent marketplace connecting patients with independent providers for rapid consultation. A consultation does not guarantee a prescription, and a marketplace model provides less built-in continuity of care for follow-up and monitoring.
Evaluation Methodology For 2026
Every clinic featured in this analysis was reviewed against publicly available pricing pages, published clinical protocols, and onboarding flows as of August 2026. Scores reflect our own editorial judgment against the five dimensions below. We did not measure patient outcomes, and no score on this page is a claim that one platform produces better weight-loss results than another. Where a platform does not publish a figure, we say so rather than estimating. We update these assessments as clinical standards and pricing change.
Our five core assessment dimensions:
Economic transparency — The stated out-of-pocket expenditure required per month, distinguishing between membership dues, lab requirements, and pharmaceutical costs, plus any minimum commitment period or early termination fee.
Medical rigor — The stated qualifications of the medical staff, the frequency of required check-ins, and the depth of ongoing physiological monitoring.
Operational efficiency — The advertised duration between initial consultation and medication delivery, plus the responsiveness of the clinical team to routine inquiries. Actual timing varies by patient.
Administrative advocacy — The platform’s dedication to managing coverage appeals, pre-approvals, and navigating pharmacy benefit managers. No platform can guarantee an approval outcome.
Technological interface — The usability of patient dashboards, integration with wearable devices, and accessibility of educational resources.
Aligning Clinics With Specific Objectives
Because metabolic profiles and financial situations differ drastically, no single platform serves every patient perfectly. Selecting the right provider depends on prioritizing your specific healthcare requirements — a decision best made with a licensed clinician who knows your medical history.
For administrative support and value: LevelsRx offers dedicated authorization assistance (disclosure: our own platform).
For intensive behavioral modification: Calibrate provides the most structured educational curriculum, while Sequence emphasizes fitness integration.
For specialized medical oversight: Accomplish Health connects you with obesity medicine clinicians, and Alfie Health uses algorithmic screening to support provider review.
For alternative pharmacological options: Found maintains the broadest catalog of non-injectable treatment pathways.
For immediate access: Sesame Care offers the quickest pathway to initial consultations.
Practices To Approach With Caution
When reviewing the expanding market of digital metabolic health providers, remain vigilant regarding these three concerning operational patterns:
Obscure dispensing pharmacies
Reputable clinics maintain full transparency regarding whether they prescribe commercially available FDA-approved medications or utilize 503A/503B compounding facilities. This distinction matters: compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality. A compounded formulation is a customized preparation made at a prescriber’s direction — it is not a generic version of, and is not equivalent to, Ozempic, Wegovy, Mounjaro, or Zepbound. Ask any platform in writing which it prescribes and which pharmacy fills it.
Predatory pricing structures
Be wary of platforms advertising low introductory rates that escalate into premium subscription tiers after the first quarter, and of advertised prices that exclude the medication itself, required lab work, or consultation fees. In 2025 the FTC brought an enforcement action against a GLP-1 telehealth company on exactly that basis. Ask for one number: total monthly cost including medication, plus any commitment period or early termination fee.
Inadequate clinical screening
Systemic metabolic medications require thorough evaluation of personal and family medical history, including thyroid complications and gastrointestinal disorders. Semaglutide and tirzepatide carry an FDA boxed warning regarding thyroid C-cell tumors observed in rodent studies and are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN 2. Platforms that prescribe without requesting lab work or detailed health histories present significant safety risks.
Commonly Raised Questions
Are these digital prescriptions valid at local pharmacies?
Usually. Legitimate telemedicine platforms utilize licensed medical professionals whose prescriptions can generally be routed to a standard brick-and-mortar pharmacy or fulfilled through affiliated mail-order services, subject to state rules and stock availability. Compounded medications are an exception — they are filled by the specific compounding pharmacy the platform works with, not a retail chain.
How long does the coverage approval process take?
Depending on your carrier, plan, and the clinic’s administrative efficiency, securing authorization typically ranges from a few days to several weeks. Some plans exclude weight-management medications entirely regardless of documentation. Platforms like LevelsRx (our own) prioritize expediting this phase, but no platform can guarantee approval.
Do I need updated bloodwork?
Most top-tier providers request recent comprehensive metabolic panels and thyroid assessments, commonly from within the last six months, before initiating advanced pharmacological therapies. Requirements vary by platform and by individual medical history.
What are the side effects of these medications?
As with all medications, GLP-1 drugs can cause side effects. Common ones include nausea, vomiting, diarrhea, constipation, and abdominal pain, particularly when starting treatment or increasing a dose. Less common but serious risks described in FDA prescribing information include pancreatitis, gallbladder disease, kidney injury from dehydration, and diabetic retinopathy complications in some patients. Semaglutide and tirzepatide also carry a boxed warning regarding thyroid C-cell tumors seen in rodent studies. Weight-loss results in clinical trials belong to the drugs as studied under trial conditions and are not a prediction of any individual’s outcome — results vary based on diet, exercise, medical history, dose, and adherence. Discuss your full medical history, including any history of disordered eating, with a licensed provider before starting.
| Last reviewed August 2026. We audit subscription rates and administrative policies quarterly. This content is for informational purposes only and does not constitute medical advice. LevelsRx publishes this guide and is featured in it. |
